| Date Filed | Type | Description |
| 05/25/2023 |
4
| Lim Bryant David (Chief Legal Officer, Corp Sec.) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Bought 2,400 shares
@ $5.39, valued at
$12.9k
|
|
| 03/02/2023 |
4
| Lim Bryant David (Chief Legal Officer, Corp Sec.) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Granted 250,000 options to buy
@ $5.93, valued at
$1.5M
|
|
| 02/22/2023 |
3
| Lim Bryant David (Chief Legal Counsel, Corp Sec.) has filed a Form 3 on Prelude Therapeutics Inc |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Lim Bryant David (SVP AND GENERAL COUNSEL) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 399,218 shares
@ $0
Paid exercise price by delivering 119,957 shares
@ $0.7099, valued at
$85.2k
|
|
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Lim Bryant David (SVP AND GENERAL COUNSEL) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 41,500 options to buy
@ $0.535, valued at
$22.2k
|
|
| 01/26/2022 |
4
| Lim Bryant David (SVP AND GENERAL COUNSEL) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 25,000 options to buy
@ $0.5746, valued at
$14.4k
|
|
| 07/12/2021 |
4
| Lim Bryant David (SVP AND GENERAL COUNSEL) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 66,500 options to buy
@ $1.11, valued at
$73.8k
|
|
| 03/29/2021 |
4
| Lim Bryant David (SVP AND GENERAL COUNSEL) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Sold 7,630 shares
@ $1.3601, valued at
$10.4k
|
|
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2020 |
4
| Lim Bryant David (SVP and General Counsel) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 shares
@ $0
Granted 50,000 options to buy
@ $1.79, valued at
$89.5k
|
|
| 01/14/2020 |
4/A
| Lim Bryant David (SVP and General Counsel) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Sold 1,603 shares
@ $1.7804, valued at
$2.9k
|
|
| 01/10/2020 |
4
| Lim Bryant David (SVP and General Counsel) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Sold 1,603 shares
@ $1.7804, valued at
$2.9k
|
|
| 07/11/2019 |
4
| Lim Bryant David (SVP and General Counsel) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 45,500 options to buy
@ $2.52, valued at
$114.7k
|
|
| 01/07/2019 |
4
| Lim Bryant David (SVP and General Counsel) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 18,100 shares
@ $0
Granted 45,500 options to buy
@ $3.14, valued at
$142.9k
|
|
| 12/26/2018 |
4
| Lim Bryant David (SVP and General Counsel) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Bought 4,000 shares
@ $3.05, valued at
$12.2k
|
|
| 11/02/2018 |
3/A
| Lim Bryant David (SVP & General Counsel) has filed a Form 3/A on IDERA PHARMACEUTICALS, INC. |
| 09/13/2018 |
4
| Lim Bryant David (SVP and General Counsel) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 130,000 options to buy
@ $9.29, valued at
$1.2M
|
|
| 09/13/2018 |
3
| Lim Bryant David (SVP and General Counsel) has filed a Form 3 on IDERA PHARMACEUTICALS, INC. |